S. Kudoh et al., DEFECTIVE GRANZYME-B GENE-EXPRESSION AND LYTIC RESPONSE IN T-LYMPHOCYTES INFILTRATING HUMAN RENAL-CELL CARCINOMA, Journal of immunotherapy, 20(6), 1997, pp. 479-487
Granzyme B is a protein thought to play a pivotal role in the cytolyti
c functions of T cells. In view of this, the inducibility of this gene
in freshly isolated T cells (T-TILs) infiltrating human renal cell ca
rcinoma (RCC) in vitro was examined by using the reverse transcriptase
-polymerase chain reaction (RT-PCR). A reduction in granzyme B messeng
er RNA (mRNA) expression in stimulated T-TILs from five of nine patien
ts with RCC compared with autologous peripheral blood T cells was note
d. The reduced expression was observed after multiple stimuli includin
g anti-CD3 antibody, interleukin-2 (IL-2), and phytohemagglutinin (PHA
). Because CD8(+) T cells represent the predominant cytotoxic populati
on, the ability of this cell population to express granzyme B mRNA aft
er stimulation also was examined. when compared with CD8(+) peripheral
blood lymphocytes (T-PBLs) from patients with RCC and normal donors,
the induction of granzyme B mRNA was reduced in CD8(+) T-TILs. CD8(+)
T-TILs also had lower non-major histocompatibility complex (MHC)-restr
icted cytotoxic activity than did CD8(+) T-PBLs against both Daudi cel
ls and allogeneic RCC cell lines. These results show that in a subset
of patients with RCC, depressed lytic activity of CD8(+) TILs compared
with CD8(+) PBLs is present. Reduced granzyme B mRNA expression also
was noted in selected patients.